image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

EMIS

December 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EMIS
  • Price:
  • 927p
EMIS has acquired 90% of Dovetail Digital, a healthcare blockchain startup, for £2.5m (£1.5m cash plus £1m equity). Dovetail has been running a pilot of its software within the NHS to give patients full control of their healthcare records, delivering secure exchange of data between health services and new digital technologies. It is early stage and will make a small loss this year.Separately, EMIS has also bought the outstanding 21.2% stake in Rx, its community pharmacy business, for £8m. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe